Trade SPRO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Spero Therapeutics, Inc. (SPRO) is trading at US$1.19, down 2.07% today as of Aug 28, 12:55 EDT. The company has a market capitalisation of US$71.05M. Over the past 52 weeks, SPRO has traded between US$1.08 and US$3.08. On Syfe you can trade SPRO with $0 commission and add it to your watchlist.
| Previous close | US$1.21 |
|---|---|
| Market cap | US$71.05M |
| P/E ratio | 3.47 |
| 52-week range | US$1.08 – US$3.08 |
| Volume | 537.63K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Spero Therapeutics, Inc.
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
Year: 2017
Sector Update: Healthcare Stocks Mixed Premarket Tuesday
Jul 14, 1:15 PM · MT Newswires
Spero Therapeutics Licenses Immunology Drug Candidate From Innovent, Recieves $105 Million Financing
Jul 14, 10:46 AM · MT Newswires
GSK, Spero Therapeutics Get FDA Approval for Utebzi in Complicated Urinary Tract Infections
Jun 17, 4:00 PM · MT Newswires
Spero Therapeutics Q4 Swings to Profit, Revenue Rises
Mar 26, 8:47 PM · MT Newswires
Spero Therapeutics, Inc. (SPRO) stock is trading at US$1.19, -2.07% from the previous close of US$1.21.
The market cap for Spero Therapeutics, Inc. (SPRO) stock is approximately US$71.05M.
The price-to-earnings ratio for Spero Therapeutics, Inc. (SPRO) is 3.47, based on the latest reported earnings.
The 52-week high for Spero Therapeutics, Inc. (SPRO) stock is US$3.08.
The 52-week low for Spero Therapeutics, Inc. (SPRO) stock is US$1.08.
Spero Therapeutics, Inc. (SPRO) does not currently pay a dividend.
Stay on top of SPRO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
